CYP2D6 genotyping in the daily routine of a psychiatric hospital - pharmacoeconomic evaluation
Today, pharmacogenetic tests are commonly used to improve the efficacy and safety of antipsychotic (AP) treatment. However, the economic aspects of their implementation in the psychiatry clinic routine are not well studied.Aim.To evaluate the pharmacoeconomic benefits of CYP2D6 polymorphisms genotyp...
Saved in:
Main Authors: | A. A. Kurylev (Author), B. V. Andreev (Author), A. S. Kolbin (Author), O. V. Limankin (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6‐Mediated Metabolic Activity
by: Rachel Dalton, et al.
Published: (2020) -
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
by: Roberta Ferraldeschi, et al.
Published: (2010) -
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018) -
PHARMACOECONOMIC ASPECT OF OMALIZUMAB APPLICATION AMONG THE PATIENTS, SUFFERING FROM THE BRONCHIAL ASTHMA
by: A.S. Kolbin, et al.
Published: (2008) -
PHARMACOECONOMIC ASPECT OF OMALIZUMAB APPLICATION AMONG THE PATIENTS, SUFFERING FROM THE BRONCHIAL ASTHMA
by: A.S. Kolbin, et al.
Published: (2008)